| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/04/2013 | US8455486 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 06/04/2013 | US8455485 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 06/04/2013 | US8455484 Selected inhibitors of protein tyrosine kinase activity |
| 06/04/2013 | US8455483 Compounds—801 |
| 06/04/2013 | US8455482 Substituted pyrrolidine derivative |
| 06/04/2013 | US8455480 Active agent combinations having insecticidal and acaricidal properties |
| 06/04/2013 | US8455479 Heterocyclic compounds |
| 06/04/2013 | US8455478 Rapid onset liquid midazolam composition for buccal administration |
| 06/04/2013 | US8455477 Therapeutic compounds |
| 06/04/2013 | US8455476 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 06/04/2013 | US8455475 Substituted spiro-amide compounds |
| 06/04/2013 | US8455474 Method for treating tuberculosis |
| 06/04/2013 | US8455473 Composition and method for irrigation of a prepared dental root canal |
| 06/04/2013 | US8455472 Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy |
| 06/04/2013 | US8455471 Compositions of CHK1 inhibitors and cyclodextrin |
| 06/04/2013 | US8455470 Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases |
| 06/04/2013 | US8455469 Use of norgestimate as a selective inhibitor of TRPC3, TRPC6 and TRPC7 ion channels |
| 06/04/2013 | US8455468 Methods for the treatment of a traumatic central nervous system injury |
| 06/04/2013 | US8455467 2-methylene-vitamin D analogs and their uses |
| 06/04/2013 | US8455465 Heat sterilised injectable composition of hyaluronic acid or one of the salts thereof, polyols and lidocaine |
| 06/04/2013 | US8455464 Dextrin containing compositions for prevention of adhesions |
| 06/04/2013 | US8455462 Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid |
| 06/04/2013 | US8455461 Compositions containing a synergic mixture of polyols and xyloglucanes as phytosanitary and bio-fertilising products |
| 06/04/2013 | US8455460 Cosmetic composition containing one or more compounds of the β-(1,3)-glucuronan or β-(1,3)-glucoglucuronan type |
| 06/04/2013 | US8455459 Method of applying an injectable filler |
| 06/04/2013 | US8455458 Composition and method for treating connective tissue damage |
| 06/04/2013 | US8455457 Combination compositions for reducing intraocular pressure |
| 06/04/2013 | US8455456 Compositions and their uses directed to diacylglycerol acyltransferase 1 |
| 06/04/2013 | US8455455 Compositions and methods for silencing genes involved in hemorrhagic fever |
| 06/04/2013 | US8455452 Composition and use of a long-acting oral bioadhesive endoparasiticide gel based on doramectin |
| 06/04/2013 | US8455451 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment |
| 06/04/2013 | US8455445 Methods for inhibiting lymphotoxin-β receptor signaling in TH1 cell-associated disorders |
| 06/04/2013 | US8455432 Insulin sensitisers and methods of treatment |
| 06/04/2013 | US8455396 Alkali metal glyphosate compositions |
| 06/04/2013 | US8455252 Materials and methods for sensitizing multidrug resistant cells |
| 06/04/2013 | US8455022 Use of a polyphenol for the treatment of a cancerous or precancerous lesion of the skin |
| 06/04/2013 | US8455004 Primary composition comprising a lipophilic bioactive compound |
| 06/04/2013 | US8455003 Chemoembolisation |
| 06/04/2013 | US8455001 Cellulose derivative and method for production thereof |
| 06/04/2013 | US8454994 Stable pharmaceutical composition and methods of using same |
| 06/04/2013 | US8454984 Antimicrobial resin compositions |
| 06/04/2013 | US8454966 Nanoparticles for protein drug delivery |
| 06/04/2013 | US8454946 N-maleimidyl polymer derivatives |
| 06/04/2013 | US8454945 Topical formulations having enhanced bioavailability |
| 06/04/2013 | US8454940 Mixtures comprising benzotriazoles and merocyanines |
| 06/04/2013 | US8454566 Methods and compositions for the inhibition of biofilms on medical devices |
| 06/04/2013 | DE202013003675U1 Mundspülöl mit Tocotrienol zur Pflege von Zahnfleisch, Zähnen und Mundhöhle Mundspülöl tocotrienol for the care of the gums, teeth and oral cavity |
| 06/04/2013 | CA2702470C Functional lipid constructs |
| 06/04/2013 | CA2692028C Azapeptide derivatives |
| 06/04/2013 | CA2664159C Carbonyl-stress improving agent and peritoneal dialysate |
| 06/04/2013 | CA2637274C Soft-gelatin capsule formulation |
| 06/04/2013 | CA2618799C Aqueous anaesthetic compositions comprising propofol |
| 06/04/2013 | CA2610749C Pharmaceutical composition comprising 2,3-dihydro-6-nitroimidazo [2,1-b]oxazole derivatives |
| 06/04/2013 | CA2583517C Composition comprising acetaminophen, caffeine and optionally aspirin together with an alkaline agent for enhanced absorption |
| 06/04/2013 | CA2580759C Method and composition for treating patients undergoing kidney dialysis |
| 06/04/2013 | CA2577862C Pharmaceutical composition comprising diclofenac |
| 06/04/2013 | CA2551022C Polyethyleneglycol-modified lipid compounds and uses thereof |
| 06/04/2013 | CA2545660C Heterocyclic inhibitors of mek and methods of use thereof |
| 06/04/2013 | CA2545659C Bicyclic inhibitors of mek |
| 06/04/2013 | CA2542609C Novel indazole derivatives |
| 06/04/2013 | CA2542419C Use of glutamyl cyclase inhibitors in the treatment of familial british dementia and familial danish dementia |
| 06/04/2013 | CA2537210C Bipolar trans carotenoid salts and their uses |
| 06/04/2013 | CA2534885C 2-(quinoxalin-5-ylsulfonylamino)-benzamide compounds as cck2 modulators |
| 06/04/2013 | CA2532789C Methods and compositions for controlling ectoparasites |
| 06/04/2013 | CA2457801C Streptococcus thermophilus strain and use thereof |
| 06/04/2013 | CA2228667C Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers |
| 06/02/2013 | CA2761068A1 Novel dosage regimens and methods for treatment, prevention, and/or management of at least one cns disorder |
| 06/01/2013 | CA2760174A1 Protein kinase inhibitors and uses thereof |
| 05/30/2013 | WO2013078477A2 Solubilization of curcuminoid compounds and products thereof |
| 05/30/2013 | WO2013078468A1 Selective kinase inhibitors |
| 05/30/2013 | WO2013078466A1 Pyrazine kinase inhibitors |
| 05/30/2013 | WO2013078441A1 Heterocyclic compounds and uses thereof |
| 05/30/2013 | WO2013078440A2 Enhanced treatment regimens using mtor inhibitors |
| 05/30/2013 | WO2013078430A1 Disubstituted beta-lactones as inhibitors of n-acylethanolamine acid amidase (naaa) |
| 05/30/2013 | WO2013078422A2 Natural combination hormone replacement formulations and therapies |
| 05/30/2013 | WO2013078413A1 Modulators of lipid storage |
| 05/30/2013 | WO2013078396A2 Radiation-sterilized biodegradable drug delivery compositions |
| 05/30/2013 | WO2013078395A1 L-serine compositions, methods and uses for treating neurodegenerative diseases and disorders |
| 05/30/2013 | WO2013078392A1 Methods and compositions involving induced senescent cells for cancer treatment |
| 05/30/2013 | WO2013078371A2 Methods and compositions for reducing alcohol toxicity |
| 05/30/2013 | WO2013078361A1 Solid state forms of vilazodone and vilazodone hydrochloride |
| 05/30/2013 | WO2013078335A1 Cysteamine and/or cystamine for treating ischemic injury |
| 05/30/2013 | WO2013078295A2 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities |
| 05/30/2013 | WO2013078259A2 Oil compositions and methods for increasing hair growth and/or preventing hair loss |
| 05/30/2013 | WO2013078254A1 Bicyclic heteroaryl derivatives as kinase inhibitors |
| 05/30/2013 | WO2013078237A1 N-arylylmethylindazole modulators of pparg |
| 05/30/2013 | WO2013078184A2 Method for treating hepatitis c virus infection using quercetin-containing compositions |
| 05/30/2013 | WO2013078151A1 Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole derivatives for treating retinal diseases |
| 05/30/2013 | WO2013078126A1 Thienopyrimidine inhibitors of atypical protein kinase c |
| 05/30/2013 | WO2013078123A1 Heterocyclic inhibitors of glutaminase |
| 05/30/2013 | WO2013078070A1 Boron-containing small molecules |
| 05/30/2013 | WO2013077881A1 Antiviral formulations |
| 05/30/2013 | WO2013077851A1 Immediate release abuse deterrent tablet |
| 05/30/2013 | WO2013077847A1 Oral dosage forms for delivering gabapentin |
| 05/30/2013 | WO2013077830A1 Synergistilly active combinations of roflumilast and carmoterol |
| 05/30/2013 | WO2013077829A1 Water-soluble pharmaceutical granules |
| 05/30/2013 | WO2013077825A1 Preparation process for a formulation comprising metformin |
| 05/30/2013 | WO2013077824A1 Preparation process for a formulation comprising metformin |
| 05/30/2013 | WO2013077823A1 Fast-dispersing nateglinide formulations |
| 05/30/2013 | WO2013077822A1 New formulations for treatment of diabetes |